Stop paying for costly EMRs, tech for connecting health systems
28 Sep 2022
Healthcare organisations should stop spending a pile of cash on expensive digital technologies to join up their systems.
During the keynote session "Shifting the Paradigm in Digital Health," Frank Hester, founder and CEO of TPP UK, shared that cost is a big consideration for him in acquiring EMR and other digital health technologies.
Say the cost of joining up health systems in Indonesia is worth a billion dollars, he said. "You should be able to bang in an EMR solution right across Indonesia for but much less than a hundred million dollars."
"I'm fine if you want to pay more… but I say it's time to stop," he urged the audience.
"In every other industry, technology has brought the cost of the product down. You get more value for money and you see it everywhere, apparently, miraculously, apart from healthcare technology," he claimed, saying that it is supposed to be cheaper, faster, and better today.
Hester also advised organisations to look from suppliers data access and interoperability in their solutions. "Have we got apps and mobile solutions? Do doctors and nurses like using the system? Does it empower them? Does it make it quicker?"
He also said to consider how quick their supplier responds; are they allowed to do the installation or wait for them to do it. "It's madness if you have to wait for your supplier to do something. It's even more madness if they managed to charge you for it," he stressed.
Nevertheless, Hester still thinks "it's a wonderful time to be in healthcare technology."
He shared that present technologies in healthcare are helping doctors save time and make fewer clinical errors.
Particularly, AI has been assisting clinicians in decision-making and diagnostics and expanding access to healthcare services, especially in areas where there is a lack of healthcare staff.
"I think the business opportunities [in healthcare technology] are fantastic, but the change that we can make to humanity, to our lives is even more fantastic," he concluded.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.